DE60235985D1 - Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) - Google Patents

Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)

Info

Publication number
DE60235985D1
DE60235985D1 DE60235985T DE60235985T DE60235985D1 DE 60235985 D1 DE60235985 D1 DE 60235985D1 DE 60235985 T DE60235985 T DE 60235985T DE 60235985 T DE60235985 T DE 60235985T DE 60235985 D1 DE60235985 D1 DE 60235985D1
Authority
DE
Germany
Prior art keywords
ntb
activity
natural killer
killer cells
implied
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60235985T
Other languages
English (en)
Inventor
Alessandro Moretta
Cristina Bottino
Roberto Biassoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innate Pharma SA
Universita degli Studi di Genova
Original Assignee
Innate Pharma SA
Universita degli Studi di Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innate Pharma SA, Universita degli Studi di Genova filed Critical Innate Pharma SA
Application granted granted Critical
Publication of DE60235985D1 publication Critical patent/DE60235985D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE60235985T 2001-07-19 2002-07-17 Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk) Expired - Lifetime DE60235985D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01401946 2001-07-19
PCT/EP2002/007945 WO2003008449A1 (en) 2001-07-19 2002-07-17 Ntb-a, a surface molecule involved in natural killer cells activity

Publications (1)

Publication Number Publication Date
DE60235985D1 true DE60235985D1 (de) 2010-05-27

Family

ID=8182813

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60235985T Expired - Lifetime DE60235985D1 (de) 2001-07-19 2002-07-17 Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)

Country Status (8)

Country Link
US (2) US7138243B2 (de)
EP (1) EP1406928B1 (de)
JP (1) JP4326944B2 (de)
AT (1) ATE464320T1 (de)
AU (1) AU2002325333B2 (de)
CA (1) CA2454185A1 (de)
DE (1) DE60235985D1 (de)
WO (1) WO2003008449A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04001986A (es) * 2001-08-29 2004-06-07 Genentech Inc Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
PT2476705E (pt) 2004-12-28 2016-02-09 Innate Pharma Anticorpos monoclonais contra nkg2a
WO2008009545A1 (en) 2006-06-30 2008-01-24 Novo Nordisk A/S Anti-nkg2a antibodies and uses thereof
WO2008027739A2 (en) * 2006-08-28 2008-03-06 Nuvelo, Inc. Antibodies to ntb-a
EP2247619A1 (de) 2008-01-24 2010-11-10 Novo Nordisk A/S Humanisierter monoklonaler anti-human-nkg2a-antikörper
BR112013032217B1 (pt) 2011-06-17 2021-01-19 Novo Nordisk A/S uso de um anticorpo anti-nkg2a
JP6449777B2 (ja) * 2012-12-21 2019-01-09 シアトル ジェネティックス， インコーポレイテッド 抗ｎｔｂ−ａ抗体ならびに関連する組成物および方法
EP4101461A1 (de) 2014-01-09 2022-12-14 Hadasit Medical Research Services and Development Ltd. Verbesserte zellenzusammensetzungen und verfahren zur krebstherapie
CN107850596B (zh) 2015-07-24 2020-12-04 先天制药公司 用于检测组织浸润nk细胞的方法
WO2019126736A1 (en) * 2017-12-21 2019-06-27 New York University Pd-1 related cancer therapy
JP7458318B2 (ja) 2018-02-12 2024-03-29 ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド 癌治療のためのｓｌａｍｆ６スプライスバリアントの調節
CN115461451A (zh) * 2020-06-09 2022-12-09 社会福祉法人三星生命公益财团 用于激活和增幅nk细胞的经基因改造的细胞株以及其用途
CN116179488A (zh) * 2023-03-09 2023-05-30 广东唯泰生物科技有限公司 外周血自然杀伤细胞的体外扩增方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4337197C1 (de) * 1993-10-30 1994-08-25 Biotest Pharma Gmbh Verfahren zur selektiven Herstellung von Hybridomazellinien, die monoklonale Antikörper mit hoher Zytotoxizität gegen humanes CD16-Antigen produzieren, sowie Herstellung bispezifischer monoklonaler Antikörper unter Verwendung derartiger monoklonaler Antikörper und des CD30-HRS-3-Antikörpers zur Therapie menschlicher Tumore
AU2001231178A1 (en) * 2000-01-25 2001-08-07 Nuvelo, Inc. Methods and materials relating to CD84-like polypeptides and polynucleotides
US7029677B2 (en) 2000-01-25 2006-04-18 Nuvelo, Inc. Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
WO2001090304A2 (en) * 2000-05-19 2001-11-29 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
EP1341814A2 (de) * 2000-09-01 2003-09-10 Genentech, Inc. Sekretierte- und transmembranpolypeptide sowie dafür kodierende nukleinsäuren
EP1223218A1 (de) * 2000-11-03 2002-07-17 Millennium Pharmaceuticals, Inc. CD2000 und CD2001 Moleküle und deren Verwendungen
US20030180888A1 (en) 2000-11-03 2003-09-25 Millennium Pharmaceuticals, Inc. CD2000 and CD2001 molecules, and uses thereof
MXPA03008591A (es) * 2001-03-22 2003-12-08 Bristol Myers Squibb Co Polinucleotido que codifica un miembro de la superfamilia novedosa de inmunoglobulina apex4, variantes y variantes de empalme del mismo.

Also Published As

Publication number Publication date
WO2003008449A8 (en) 2004-02-26
US20050159332A1 (en) 2005-07-21
EP1406928A1 (de) 2004-04-14
JP4326944B2 (ja) 2009-09-09
WO2003008449A1 (en) 2003-01-30
US7138243B2 (en) 2006-11-21
JP2005507648A (ja) 2005-03-24
CA2454185A1 (en) 2003-01-30
EP1406928B1 (de) 2010-04-14
ATE464320T1 (de) 2010-04-15
US20070065875A1 (en) 2007-03-22
AU2002325333B2 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
WO2002031134A3 (en) Novel serine protease genes related to dppiv
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
WO2006042158A3 (en) Methods and compositions for improving recombinant protein production
DE60235985D1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
ATE416258T1 (de) Säure-pilzprotease bei der fermentation von nichtlöslichen stärkesubstraten
ATE543506T1 (de) Methode zur stabilisierung von proteinen
ATE500323T1 (de) Subtilisin-variante
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE414775T1 (de) Polypeptide mit prolyldipeptidylaminopeptidase- aktivität und dafür kodierende nukleinsäuren
MX2010003055A (es) Nuevas citocinas aviares y secuencias geneticas que las codifican.
ATE484587T1 (de) Ldcam genannte moleküle
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
DE69837475D1 (de) Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren
BRPI0412607A (pt) método para aprimorar a eficácia de proteìnas modificantes de reação biológica e muteìnas resultantes
WO2000043493A8 (en) Metalloproteinase adam 22
ATE557092T1 (de) Bv8-nukleinsäuren und polypeptide mit mitogener aktivität
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
DE60139113D1 (de) 18477, eine menschliche proteinkinase und deren verwendung
WO1998027932A3 (en) Cerebellum and embryo specific protein
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
DE60027563D1 (de) Fc-Fusionsproteine des MENSCHLICHEN TUMOR-NEKROSE-FAKTOR-Rezeptors TR10
WO2001079525A3 (en) Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition